EBGene trial: patient preselection outcomes for the European GENEGRAFT ex vivo phase I/II gene therapy trial for recessive dystrophic epidermolysis bullosa.
Gaucher S,Lwin S,Titeux M,Abdul-Wahab A,Pironon N,Izmiryan A,Miskinyte S,Ganier C,Duchatelet S,Mellerio J,Bourrat E,McGrath J,Hovnanian A
Source :
Br. J. Dermatol.
2019 Nov 27
Pmid / DOI:
31557321